Bringing Innovative Solutions to Healthcare Practitioners.
NeuroAiD™II awarded Gold accreditation by
independent nonprofit Empowered By Evidence (EBE)
Bringing Innovative Solutions to Healthcare Practitioners
A Focus on Neurology
Since Moleac was founded, our ambition is to provide new solutions to supplement the therapeutic armamentarium for conditions where significant unmet needs remain. To achieve this goal, we develop natural products according to international standards and commercialize our products worldwide.
Our products are developed by Moleac with scientific excellence and evidence-based approach.
Together with our R&D department and world renowned experts, we have successfully developed and marketed NeuroAiD, the world’s first post-stroke recovery treatment, helping patients to regain functional independence after a stroke or a traumatic brain injury by amplifying endogenous processes of brain repair. NeuroAiD is available in over 30 countries worldwide.
Challenging the Boundaries Of The Possible.
OUR INNOVATION TO RECONNECT AFTER A BRAIN INJURY
NeuroAiD is an oral treatment helping patients of brain and spinal cord injuries who suffer from established deficits to recover their functional independence in addition to rehabilitation therapy and exercises. NeuroAiD also supports cognitive functions in Alzheimer’s Disease.
Patients taking NeuroAid yearly
Awards
Countries with Exclusive Partnership
Shaping the Future of Neurological Care
Latest News
Advancing Stroke Recovery: Highlights from Moleac’s Scientific Meeting in Singapore
Advancing Care for Neurological Disorders
Can AI Improve Early Alzheimer’s Detection? Insights from Multimodal Brain Imaging and Genomic Data
From Trauma to Recovery: Highlights from the NeuroAiD Expert Meeting in Poland
Advancing Alzheimer’s Care: Highlights from Moleac’s Convention in Da Nang
This past weekend, Moleac hosted the Advancing Care for Alzheimer’s Disease Convention in Da Nang, Vietnam.
World Alzheimer’s Day: Raising Awareness and Advancing Neurological Care
Today is World Alzheimer’s Day. Alzheimer’s disease affects millions of people worldwide, as well as the families and caregivers supporting them.
World Alzheimer’s Day: Understanding the Stages of Alzheimer’s Disease
Alzheimer’s disease progresses differently for every person.
Meet Moleac at CPHI Shenzhen 2026: Connecting for Global Healthcare Innovation
Moleac is pleased to attend CPHI Shenzhen 2026.
Ahead of World Alzheimer’s Day: Understanding Alzheimer’s Disease and the Importance of Early Awareness
Ahead of World Alzheimer’s Day, learn about Alzheimer’s disease, its progression, and why early awareness matters.
Spinal Cord Injury Day: Advancing Recovery, Care and Quality of Life
Today is Spinal Cord Injury Day!
